BoneHealth.MediaIntelligence
Intelligence Series

Systems & policy research
for the bone health field.

A working paper series examining the structural forces shaping bone health investment, care delivery, and field infrastructure. Written for payers, investors, health system leaders, and clinicians who shape what happens next.

6
Papers in Series
1
Available Now
4–6 wk
Release Cadence
Free
Access
The BHM Intelligence Series examines bone health not as a clinical problem but as a systems and infrastructure problem — one shaped by misaligned incentives, fragmented data, and structural underinvestment. Each paper addresses a distinct dimension of this challenge, written for decision-makers who need analysis, not abstracts.
Written For
Payers & Health Plans Investors Health System Leaders Clinicians Industry & Pharma Policy & Government
01
The Unintended Dividend \'97 cover
The Unintended Dividend
How SABRE Could Restructure the Operational Landscape of Bone Health
A December 2025 FDA regulatory decision designed to accelerate osteoporosis drug development may have created — as an unintended consequence — the conditions under which the field could finally build the patient discovery infrastructure it has always needed but never had sufficient urgency to fund.
10M+ Americans with Osteoporosis
80% Fracture Patients Who Receive No Treatment
2019 Last Year a New Osteoporosis Drug Was Approved
Opportunistic Imaging AI Diagnostics FDA & Regulatory Market Infrastructure
Revised and Expanded Edition · March 2026 · Published by Bone Health Media · bonehealth.media
02
Unlocking Refrigerated Capital \'97 cover
Unlocking Refrigerated Capital
A Structural Investment Reset for Bone Health
A meaningful portion of the capital needed to scale bone health infrastructure already exists within the system. It is not missing. It is immobilized — locked inside drug inventory held in clinic refrigerators across thousands of independent community practices nationwide.
$5–6B Annual U.S. Injectable Osteoporosis Market
$200–450M Working Capital Immobilized Nationally
$12–36M Estimated Annual Economic Drag
Working Capital Drug Distribution Independent Practices Investment Infrastructure
Coming Soon
Companion to: The Unintended Dividend — BHM Intelligence Series No. 001
03
In Development BHM Intelligence Series · Vol. 3
Follow the Money
Sources and Uses of Capital in Bone Health
Follow the Money attempts the first structured accounting of capital sources and uses across the bone health ecosystem — and finds a field that is not capital-starved, but profoundly capital-misaligned.
Capital Flows Investment Infrastructure Ecosystem Finance Structural Analysis
In Development
BHM Intelligence Series · No. 001
The Unintended Dividend
How SABRE Could Restructure the Operational Landscape of Bone Health
Enter your details to access the full working paper. You’ll receive new releases directly as they publish.
First Name
Last Name
Email Address *
Organization / Title
Something went wrong. Please try again or email info@bonehealth.media

Your download is ready.

The paper will open in a new tab. Check your inbox for future releases.

About the Series
Systems & Policy Research
The BHM Intelligence Series is not clinical or economic research in the academic sense. It is systems and policy analysis — written to inform decisions, surface structural problems, and propose actionable frameworks for the people and institutions positioned to act.
Distribution
Working Paper Format
Papers are published as PDF working papers on bonehealth.media and distributed via the BHM subscriber list. Each paper is free to access and intended for wide circulation among healthcare decision-makers, investors, and policy professionals. Contact info@bonehealth.media for reprint or distribution inquiries.
Stay Current
New Papers Every 4–6 Weeks
Papers release on a rolling cadence through 2025–2026. Register to access available papers and receive new releases directly. Contact info@bonehealth.media for reprint or distribution inquiries.
Contact
info@bonehealth.media